儿童和青少年的慢性髓性白血病
Moran Gotesman1, Sahar Raheel2, Eduard H Panosyan1
1Department of Pediatrics, Harbor UCLA Medical Center, 1000 West Carson Street Box 468, Torrance, CA 90509, USA; The Lundquist Institute of Biomedical Innovation, 1124 West Carson Street, Torrance, CA 90502, USA.
儿童白血病,主要是急性白血病,用氨酸激酶抑制剂 (TKIs) 进行治疗,以缓解和治愈. 长期监测TKI的影响在儿科瘤学中至关重要.
科学领域:
- 儿科瘤学 儿科瘤学
- 血液学 血液学 血液学
- 癌症研究 癌症研究
背景情况:
- 急性白血病是最常见的儿童癌症.
- 慢性髓性白血病 (CML) 是一种罕见的儿科恶性瘤,影响儿童白血病病例的2-3%和青少年的9%.
- 慢性慢性ML的发病率很低,儿童和青少年每年每百万分别有1例和2.2例.
研究的目的:
- 为了总结儿科白血病的管理.
- 突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出突出
- 强调监测儿童TKI治疗的长期影响的重要性.
主要方法:
- 关于儿童白血病治疗的文献综述.
- 对儿童白血病发病率的分析.
- 专注于涉及技术知识的治疗策略.
主要成果:
- 急性白血病是儿童中占主导地位的形式.
- 慢性髓性白血病在儿科患者中明显不常见.
- 儿童TKIs是儿童白血病的关键治疗方式.
结论:
- 儿童白血病的有效治疗旨在缓解和治愈.
- 氨酸激酶抑制剂是现代儿科白血病管理的核心.
- 密切监测TKI的不良事件和长期后果对于儿科患者至关重要.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Lineage Commitment
